Elite Pharmaceuticals, Inc.

ELTP · OTC
Analyze with AI
3/31/2025
3/31/2024
3/31/2023
3/31/2022
Assets
Cash & Equivalents$11,315$7,106$7,832$8,535
Short-Term Investments$0$0$0$0
Receivables$29,207$19,453$3,095$3,058
Inventory$16,240$12,930$9,551$6,741
Other Curr. Assets$976$524$1,033$527
Total Curr. Assets$57,739$40,014$21,510$18,861
Property Plant & Equip (Net)$14,099$14,610$10,439$6,985
Goodwill$0$0$0$0
Intangibles$5,638$6,341$6,341$6,634
Long-Term Investments$454$433$21$405
Tax Assets$18,366$22,161$2,172$2,172
Other NC Assets$92$527$412$92
Total NC Assets$38,648$43,639$19,386$16,288
Other Assets$0$0$0$0
Total Assets$96,387$83,654$40,896$35,149
Liabilities
Payables$2,958$2,714$2,447$1,431
Short-Term Debt$5,082$5,020$326$557
Tax Payable$341$485$415$415
Deferred Revenue$6$13$13$13
Other Curr. Liab.$3,455$4,816$8,758$4,278
Total Curr. Liab.$11,840$13,050$7,834$6,694
LT Debt$5,833$6,717$3,562$2,225
Deferred Rev, NC$0$6$19$32
Deferred Tax Liab, NC$0$0-$4,082,709$0
Other NC Liab.$25,199$6,298$522$976
Total NC Liab.$31,032$13,021$4,102$3,233
Other Liabilities$0$0$0$0
Cap. Leases$3,635$4,162$15$1,039
Total Liabilities$42,872$26,071$11,936$9,927
Equity
Pref Stock$0$0$0$0
Common Stock$1,068$1,068$1,014$1,011
Retained Earnings-$120,704-$116,389-$136,498-$140,060
AOCI$0$0$0$0
Other Equity$173,150$172,904$164,444$164,270
Total Equity$53,515$57,583$28,960$25,222
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$96,387$83,654$40,896$35,149
Net Debt-$400$4,632-$3,945-$5,754